Forum Topic

The Indian Government will stockpile the Oxford-AstraZeneca vaccine until March as part of a nationwide vaccination drive, delaying its wider distribution to the developing world. The Serum Institute of India (SII), which has gained a licence to produce at least one billion doses of the Oxford-AstraZeneca vaccine, was granted emergency use authorisation by the Indian Government on Sunday on the condition that it doesn’t export the shots.Global health experts have expressed concern that the move means “the pharmacy of the developing world has shut its doors” – India is the largest producer of generic medicines in low- and middle-income nations.But within the country, which has suffered the world’s second-largest Covid-19 epidemic, the urgency to rapidly roll out a mass-vaccination program to India's 1.38 billion citizens is mounting.Though the number of new daily cases has fallen to their lowest in six months in India, the presence of the highly contagious UK strain of Covid-19 has led to fears of a new surge.  “India’s Covid-19 warriors – frontline health workers and essential service providers – will now be protected by the vaccine,” said Dr Jyoti Joshi, the Head of South Asia at the Center for Disease Dynamics, Economics and Policy. “This is welcome news as India is among the worst affected countries by the virus.”https://www.telegraph.co.uk/global-health/science-and-disease/pharmacy-developing-world-shuts-doors-india-stockpiles-oxford/

Bernard Allen ● 1193d